Page last updated: 2024-12-08

argipressin, asu(1,6)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID168160
MeSH IDM0110378

Synonyms (12)

Synonym
deamino-dicarba-argipressin
[asu1,6,arg8]-vasopressin
40944-53-4
n-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[11-(2-amino-2-oxoethyl)-8-(3-amino-3-oxopropyl)-5-benzyl-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,20-pentaoxo-1,4,7,10,13-pentazacycloicosane-14-carbonyl]pyrrolidine-2-carboxami
arginine vasopressin, asu(1,6)-
24057-83-8
asu-avp
1,6-dicarbavasopressin, 1-butanoic acid-8-l-arginine-
vas-a
1,6-asu-argipressin
argipressin, asu(1,6)-
argipressin, aminosuberoyl(1,6)-

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response measurements with AVP-A showed ED50 values of 76 and 62 nM for PA and PI labeling, respectively."( Vasopressin rapidly stimulates phosphatidic acid-phosphatidylinositol turnover in rat anterior pituitary cells.
Labrie, F; Leung, PC; Raymond, V; Veilleux, R, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (16.67%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]